Literature DB >> 14506038

Pentamidine is active in vitro against Fusarium species.

Michail S Lionakis1, Russell E Lewis, George Samonis, Dimitrios P Kontoyiannis.   

Abstract

Fusariosis is an emerging opportunistic mycosis against which currently used antifungals have limited activity. Here, we investigated the in vitro activities of pentamidine (PNT) against 10 clinical isolates of Fusarium species (five Fusarium solani isolates and five non-F. solani isolates) by using the National Committee for Clinical Laboratory Standards microdilution method in three different media (RPMI, RPMI-2, and a yeast nitrogen base medium), disk diffusion testing, and viability dye staining. PNT had significant activities against all 10 Fusarium isolates. Non-F. solani isolates were more susceptible than F. solani isolates (P < 0.05). Additionally, PNT was fungicidal against all non-F. solani isolates, whereas it had fungistatic effects against four of the five F. solani isolates. PNT also exhibited greater activity against conidial than against hyphal development of the fungus. This fungicidal activity against non-F. solani Fusarium isolates was confirmed microscopically after staining of PNT-treated Fusarium oxysporum hyphae with the fluorescent viability dyes 5,(6)-carboxyfluorescein diacetate (CFDA) and bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC). The MICs at which 50% of the isolates were inhibited (2 micro g/ml for non-F. solani isolates and 4 micro g/ml for F. solani isolates) and the minimum fungicidal concentration at which 50% of the isolates were killed (8 micro g/ml for non-F. solani isolates) were much lower than the PNT tissue concentrations previously reported in humans using conventional daily intravenous PNT dosing. Finally, PNT was more active against Fusarium isolates in a hypoxic environment of in vitro growth (P < 0.05). This finding may be clinically significant, because Fusarium, an angiotropic mold, causes tissue infarcts with resultant low tissue perfusion. Our findings suggest that PNT may have a role in the management of Fusarium infections. Future in vivo studies are needed to verify these in vitro findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506038      PMCID: PMC201137          DOI: 10.1128/AAC.47.10.3252-3259.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

Authors:  J Guarro; I Pujol; E Mayayo
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Assessment of the effect of amphotericin B on the vitality of Candida albicans.

Authors:  R S Liao; R P Rennie; J A Talbot
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi.

Authors:  J Guarro; C Llop; C Aguilar; I Pujol
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 4.  Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.

Authors:  S D Morris-Jones; P J Easterbrook
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

5.  Experimental pathogenicity of four opportunist Fusarium species in a murine model.

Authors:  E Mayayo; I Pujol; J Guarro
Journal:  J Med Microbiol       Date:  1999-04       Impact factor: 2.472

6.  Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies.

Authors:  K O'Donnell; H C Kistler; E Cigelnik; R C Ploetz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  Effect of pentamidine on the growth of Cryptococcus neoformans.

Authors:  F Barchiesi; M Del Poeta; V Morbiducci; F Ancarani; G Scalise
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

8.  In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.

Authors:  I Pujol; J Guarro; J Gené; J Sala
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

9.  Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; S Nangia; J H Rex
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

10.  Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.

Authors:  T Koizumi; K Kubo; T Kaneki; M Hanaoka; T Hayano; T Miyahara; K Okada; K Fujimoto; H Yamamoto; T Kobayashi; M Sekiguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  7 in total

1.  Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis.

Authors:  Michail S Lionakis; Georgios Chamilos; Russell E Lewis; Nathan P Wiederhold; Issam I Raad; George Samonis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 3.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Invasive fusariosis masquerading as extramedullary disease in rapidly progressive acute lymphoblastic leukemia.

Authors:  John A Ligon; Mukil Natarajan; Haneen Shalabi; Bonnie Yates; Rachel Bishop; David Bianchi; Alvaro Alencar; Michail S Lionakis; Nirali N Shah
Journal:  Pediatr Blood Cancer       Date:  2019-03-22       Impact factor: 3.167

5.  Metabolism and resistance of Fusarium spp. to the manzamine alkaloids via a putative retro pictet-spengler reaction and utility of the rational design of antimalarial and antifungal agents.

Authors:  Noer Kasanah; Lorelei Lucas Farr; Abbas Gholipour; David E Wedge; Mark T Hamann
Journal:  Mar Biotechnol (NY)       Date:  2014-02-20       Impact factor: 3.619

6.  Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.

Authors:  Jinqing Zhang; Wei Liu; Jingwen Tan; Yi Sun; Zhe Wan; Ruoyu Li
Journal:  Mycopathologia       Date:  2013-01-23       Impact factor: 2.574

7.  Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Authors:  Rafael A Oechsler; Michael R Feilmeier; Darlene Miller; Wei Shi; Ana Luisa Hofling-Lima; Eduardo C Alfonso
Journal:  Cornea       Date:  2013-05       Impact factor: 2.651

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.